Shorla Oncology® Announces U.S. FDA Approval of Larger Vial Size for Nelarabine Intravenous Administration for the Treatment of T-cell Acute Lymphoblastic Leukemia and T-cell Lymphoblastic Lymphoma ...
New 375mg vial addresses critical dosing gap for adult and pediatric patients living with T-cell Acute Lymphoblastic Leukemia and T-cell Lymphoblastic Lymphoma Shorla Oncology ('Shorla'), a ...
Ross High School student using cancer journey to raise money, awareness ...
BOSTON, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced that the U.S. Food and Drug ...
Audrey Baxter, a senior at Eagle High School is raising awareness for leukemia in memory of her mom, who passed in March 2024. Immigration officers assert sweeping power to enter homes without a judge ...
Add Yahoo as a preferred source to see more of our stories on Google. Audrey Baxter, a senior at Eagle High School is raising awareness for leukemia in memory of her mom, who passed in March 2024.
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced updated efficacy and safety results from the ongoing QUILT-106 clinical study (NCT06334991) evaluating an ...
Durable complete responses with CAR-NK + Rituximab in patients who failed current standards of care in Waldenstrom’s Non-Hodgkins lymphoma (NHL). Long-term evaluable patients demonstrate ongoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results